These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 8191164

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Willebrand's disease and multimeric analysis of the Willebrand factor].
    Hauert J, Tran-Thang C, Bachmann F.
    Schweiz Med Wochenschr; 1985 Dec 07; 115(49):1773-5. PubMed ID: 3879003
    [Abstract] [Full Text] [Related]

  • 5. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
    Giannini S, Mezzasoma AM, Leone M, Gresele P.
    Haematologica; 2007 Dec 07; 92(12):1647-54. PubMed ID: 18055988
    [Abstract] [Full Text] [Related]

  • 6. [Diagnostic strategies for detection of the von Willebrand syndrome].
    Eller T, Mayer J, Bomhard M, Keller F.
    Beitr Infusionsther; 1992 Dec 07; 30():268-71. PubMed ID: 1284714
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease.
    Favaloro EJ.
    Blood Rev; 1999 Dec 07; 13(4):185-204. PubMed ID: 10741895
    [Abstract] [Full Text] [Related]

  • 9. Improved characterization of plasma von Willebrand factor heterogeneity when using 2.5% agarose gel electrophoresis.
    Mazurier C, Samor B, Goudemand M.
    Thromb Haemost; 1986 Feb 28; 55(1):61-4. PubMed ID: 3486491
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. von Willebrand factor antigen is less sensitive than ristocetin cofactor for the diagnosis of type I von Willebrand disease--results based on an epidemiological investigation.
    Rodeghiero F, Castaman G, Tosetto A.
    Thromb Haemost; 1990 Nov 30; 64(3):349-52. PubMed ID: 2096485
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
    Gadisseur A, van der Planken M, Schroyens W, Berneman Z, Michiels JJ.
    Acta Haematol; 2009 Nov 30; 121(2-3):145-53. PubMed ID: 19506361
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The multimeric pattern of von Willebrand's factor (vWF) can be demonstrated also in the severe form of the disease.
    Pezzetti L, Redaelli R, Caimi TM, Cattaneo D, Baudo F, De Cataldo F.
    Int J Hematol; 1992 Feb 30; 55(1):89-91. PubMed ID: 1581588
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.